| Issue Date | Title | Author(s) |
| 2024 | Correction To: Integrated Systems Biology Analysis of Acute Lymphoblastic Leukemia: Unveiling Molecular Signatures and Drug Repurposing Opportunities (annals of Hematology, (2024), 10.1007/S00277-024-05821-w) | Budak, B.; Tükel, E.Y.; Turanlı, B.; Kiraz, Y. |
| 2024 | Identification of Potential Inhibitors for Drug Resistance in Acute Lymphoblastic Leukemia Through Differentially Expressed Gene Analysis and in Silico Screening | Özay, Başak; Tükel, Ezgi Yağmur; Ayna Duran, Gizem ; Kiraz, Yağmur |
| 2023 | In Silico Approach for Identification of Pi3k/Mtor Dual Inhibitors for Multiple Myeloma Treatment | Masalacı, İlke; Akdoğan, Yaren; Mutlu Özge; Eyvaz, Hande; Kıraz, Yağmur |
| 2024 | In Silico Drug Repurposing Against Psmb8 as a Potential Target for Acute Myeloid Leukemia Treatment | Tukel, Ezgi Yağmur; Ateş, Onur; Kiraz, Yağmur |
| 2024 | In Silico Target Determination and Identification of Novel Agents Against Chemoresistant Acute Lymphoblastic Leukemia | Özay, Başak |
| 2024 | Increasing Treatment Efficacy by Drug Repositioning in Acute Lymphoblastic Leukemia | Tükel, Ezgi̇ Yağmur |
| 2024 | Increasing Treatment Efficacy by Drug Repositioning in Acute Lymphoblastic Leukemia | Kiraz, Y. ; Tukel, E. Y.; Budak, B.; Turanli, B. |
| 2024 | Integrated Systems Biology Analysis of Acute Lymphoblastic Leukemia: Unveiling Molecular Signatures and Drug Repurposing Opportunities | Budak, Betül; Tükel, Ezgi Yağmur; Turanlı, Beste; Kiraz, Yağmur |
| 2022 | Molecular Characterization of Multiple Myeloma | Kiremitçi, B. Zeren; Gürler, Elif Serap; Kiraz, Yağmur |
